They haven't amended yet right? Has the company publicly disclosed how they intend to work around the point you have raised, based on the company data that surely they are aware of?.....Have they even addressed this topic disclosed by their own trial data? I realize we are just 3 months post data release but surely your concern is to be taken serious by the company? or no? Do you recall whether Doc238 has opinioned on this observation you raise?